亚太地区神经修复和再生市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品(神经刺激和神经调节设备 {内部神经刺激设备 [脊髓刺激、深部脑刺激、迷走神经刺激、骶神经刺激) 、胃电刺激]和外部神经刺激装置[经皮电神经刺激装置、经颅磁刺激装置、呼吸电刺激装置]}和生物材料)和应用(神经刺激和神经调节应用{内部神经刺激和神经调节,以及外部神经刺激和神经调节},以及神经修复和再生应用{直接神经修复/神经修补[神经外膜修复、神经周围修复和群束修复]、神经移植[自体移植、同种异体移植和异种移植]和干细胞治疗})

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 204    |    Report Code: BMIRE00027563    |    Category: Life Sciences

Asia Pacific Nerve Repair & Regeneration Market

神经修复与修复亚太地区再生市场预计将从2022年的12.6683亿美元增长到2028年的22.6379亿美元;预计 2022 年至 2028 年复合年增长率为 10.2%。

 

产品发布和批准为亚太地区神经修复与治疗提供机会再生市场参与者

 

一些神经修复和再生市场参与者正在推出各种产品,例如内部神经刺激装置、外部神经刺激装置、神经导管、神经包裹物、神经连接器和其他生物材料,以增强神经修复和再生的治疗输出。他们还提供神经调节剂、神经刺激和生物材料设备等产品。这些设备用于治疗神经退行性疾病或创伤性疾病,例如帕金森病、阿尔茨海默病、硬化症、多系统萎缩症和肌萎缩侧索硬化症。例如,2022年7月,Checkpoint Surgical推出了Checkpoint Edge神经切割套件,扩大了公司的术中神经护理产品组合。 Checkpoint Edge 神经切割套件是 Checkpoint Surgical 计划的神经专用器械产品组合中的第一个产品,未来计划进一步扩展。此外,2022年3月,Integra LifeSciences Holding Corporation推出了NeuraGen 3D Nerve Guide Matrix,这是一种用于修复周围神经中断的可吸收植入物。 NeuraGen 3D 是一款神经修复产品,专门设计用于开发优化的环境,与中空神经导管相比,该环境可在中间隙神经修复后实现更全面的功能恢复。 2021 年 8 月,Checkpoint Surgical, Inc. 推出了 NeuroShield 壳聚糖神经包裹,以扩大其术中神经护理产品线。 NeuroShield Wrap 标志着该公司计划中的基于壳聚糖的生物植入物系列中的第一个产品,以支持神经愈合。该产品补充了 Checkpoint Surgical 的现有产品组合,包括该公司的旗舰产品 Checkpoint 神经刺激器/定位器,这是用于术中神经保护和修复的领先神经刺激设备。因此,市场参与者积极参与产品创新和开发以及产品批准的增加可能会推动未来几年的市场增长。

 

< p>

市场概览

 

亚太地区是神经修复和治疗领域增长最快的区域市场;再生。亚太神经修复与治疗中心再生市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。日本已占亚太神经修复及治疗市场30.8%的份额由于神经损伤发生率不断上升、神经系统疾病患病率较高、医疗旅游业不断增长,以及政府对该国神经系统疾病研究的支持不断增加,预计 2021 年的再生市场将会出现。这些因素预计将推动亚太地区神经修复和神经修复的发展。未来几年的再生市场。

 

亚太神经修复与再生市场到 2028 年再生市场收入及预测(百万美元)

             

 

亚太神经修复与治疗中心再生市场细分

 

亚太地区神经修复与再生市场再生市场分为产品和应用。

  • 根据模拟器类型,市场分为神经刺激和神经调节设备以及生物材料神经刺激和神经调节设备细分市场在 2022 年占据了最大的市场份额。
  • 根据应用情况,市场分为神经刺激和神经刺激。神经调节应用和神经修复与治疗再生应用。神经修复与修复再生应用领域在 2022 年占据最大的市场份额。
  • 根据国家/地区,亚太地区的神经修复和再生应用领域占据了最大的市场份额。再生市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。日本在 2022 年占据市场主导地位。

Axogen Corporation、Boston Scientific Corporation、Integra LifeSciences、Medtronic、Abbott Laboratories、Stryker Corporation、Neuronetics、LivaNova PLC、Baxter、和 Polyganics BV 是神经修复和神经修复领域的领先公司。亚太地区的再生市场。  



Asia Pacific Nerve Repair & Regeneration Strategic Insights

Strategic insights for Asia Pacific Nerve Repair & Regeneration involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-nerve-repair-and-regeneration-market-strategic-framework.webp
Get more information on this report

Asia Pacific Nerve Repair & Regeneration Report Scope

Report Attribute Details
Market size in 2022 US$ 1,266.83 Million
Market Size by 2028 US$ 2,263.79 Million
Global CAGR (2022 - 2028) 10.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 神经刺激和神经调节设备
  • 生物材料
By 应用
  • 神经刺激和神经调节应用
  • 神经修复和再生应用
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Axogen Corporation
  • Boston Scientific Corporation
  • Integra LifeSciences
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Neuronetics
  • LivaNova PLC
  • Baxter
  • Polyganics BV
  • Get more information on this report

    Asia Pacific Nerve Repair & Regeneration Regional Insights

    The regional scope of Asia Pacific Nerve Repair & Regeneration refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-nerve-repair-and-regeneration-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Nerve Repair & Regeneration Market

    1. Axogen Corporation
    2. Boston Scientific Corporation      
    3. Integra LifeSciences
    4. Medtronic
    5. Abbott Laboratories
    6. Stryker Corporation
    7. Neuronetics
    8. LivaNova PLC
    9. Baxter
    10. Polyganics BV
    Frequently Asked Questions
    How big is the Asia Pacific Nerve Repair & Regeneration Market?

    The Asia Pacific Nerve Repair & Regeneration Market is valued at US$ 1,266.83 Million in 2022, it is projected to reach US$ 2,263.79 Million by 2028.

    What is the CAGR for Asia Pacific Nerve Repair & Regeneration Market by (2022 - 2028)?

    As per our report Asia Pacific Nerve Repair & Regeneration Market, the market size is valued at US$ 1,266.83 Million in 2022, projecting it to reach US$ 2,263.79 Million by 2028. This translates to a CAGR of approximately 10.2% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Nerve Repair & Regeneration Market report typically cover these key segments-

  • 产品 (神经刺激和神经调节设备, 生物材料)
  • 应用 (神经刺激和神经调节应用, 神经修复和再生应用)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Nerve Repair & Regeneration Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Nerve Repair & Regeneration Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Nerve Repair & Regeneration Market?

    The Asia Pacific Nerve Repair & Regeneration Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Axogen Corporation
  • Boston Scientific Corporation
  • Integra LifeSciences
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Neuronetics
  • LivaNova PLC
  • Baxter
  • Polyganics BV
  • Who should buy this report?

    The Asia Pacific Nerve Repair & Regeneration Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Nerve Repair & Regeneration Market value chain can benefit from the information contained in a comprehensive market report.